Cognition Therapeutics Inc (CGTX) — Cash Flow Reinvestment Rate
Latest as of December 2021:
0.53x
Cognition Therapeutics Inc (CGTX) has a Cash Flow Reinvestment Rate of 0.53x as of December 2021, reinvesting $54.00K (capex $27.00K plus investments $-27.00K) from operating cash flow of $101.00K. See CGTX cash flow after capex ratio to measure how efficiently the company converts operating cash flow to free cash.
Reinvestment Rate
0.53x
(Capex + Investments) / Operating CF
Total Reinvested
$54.00K
Capex + Investments
Operating Cash Flow
$101.00K
USD
Capital Expenditures
$27.00K
USD
Annual Cash Flow Reinvestment Rate for Cognition Therapeutics Inc (None–None)
Year-by-year capital reinvestment analysis for Cognition Therapeutics Inc. See financial agility of Cognition Therapeutics Inc to measure the company's free cash flow as a share of total liabilities.
| Year | Reinvestment Rate | Total Reinvested (USD) | Operating CF | Capex | YoY Change |
|---|
Cash Flow Reinvestment Rate = (ABS(Capex) + ABS(Investments)) / Operating Cash Flow